Navidea Biopharmaceuticals, Inc.
(NYSE Amex Equities : NAVB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.35%147.630.7%$944.81m
PFEPfizer Inc. 1.04%36.430.9%$901.32m
MRKMerck & Co., Inc. -0.10%82.850.7%$691.72m
ABBVAbbVie, Inc. 1.38%87.421.9%$686.52m
BMYBristol-Myers Squibb Co. 0.62%59.861.0%$641.75m
LLYEli Lilly & Co. -1.03%148.711.1%$555.98m
AZNAstraZeneca Plc -1.34%54.771.2%$254.30m
NVSNovartis AG 0.02%87.130.2%$163.92m
GSKGlaxoSmithKline Plc 0.09%37.840.2%$109.29m
PRNBPrincipia Biopharma, Inc. 0.00%100.050.0%$86.76m
NVONovo Nordisk A/S 0.17%69.180.1%$57.76m
RGENRepligen Corp. 1.87%147.007.1%$50.47m
SNYSanofi 0.35%50.960.2%$49.17m
RPRXRoyalty Pharma Plc 2.31%41.000.2%$48.10m
OPKOPKO Health, Inc. -1.40%3.1811.2%$43.02m

Company Profile

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.